Skip to main content

The “Science” And Politics of Coronavirus

The New York Times, the old grey lady of eastern seaboard journalism, has published a blockbuster story, “Your Coronavirus Test Is Positive. Maybe It Shouldn’t Be,” that should be widely reported in other media formats. So far, the substance of the story has remained pretty much on the media shelf.

The Times has discovered that the easily corrected, most often used calibration for Coronavirus testing is not useful for "containing the spread of the virus.”

According to the Times, “In three sets of testing data that include cycle thresholds, compiled by officials in Massachusetts, New York and Nevada, up to 90 percent of people testing positive carried barely any virus, a review by The Times found.

“On Thursday [8/10/.2020], the United States recorded 45,604 new Coronavirus cases, according to a database maintained by The Times. If the rates of contagiousness in Massachusetts and New York were to apply nationwide, then perhaps only 4,500 of those people may actually need to isolate and submit to contact tracing.

The difference between 45,000 and 4,500 is, scientists and reporters may note, not a rounding error.

Leading public health experts are concerned: “Some of the nation’s leading public health experts are raising a new concern in the endless debate over Coronavirus testing in the United States: The standard tests are diagnosing huge numbers of people who may be carrying relatively insignificant amounts of the virus.”

To put the matter in terms non-scientists may understand -- current Coronavirus testing is so over calibrated it cannot discover the four leaf clover in a massive field of clover.

“The most widely used diagnostic test for the new Coronavirus, called a PCR test,” the paper notes, “provides a simple yes-no answer to the question of whether a patient is infected.” However, similar PCR tests for other viruses, “do offer some sense of how contagious an infected patient may be: The results may include a rough estimate of the amount of virus in the patient’s body.”

Dr. Michael Mina, an epidemiologist at the Harvard T.H. Chan School of Public Health, is calling for testing that can find the four leaf clover: “We’ve been using one type of data for everything, and that is just plus or minus — that’s all. We’re using that for clinical diagnostics, for public health, for policy decision-making.

But yes-no isn’t good enough, he says, according to the Times story, “It’s the amount of virus that should dictate the infected patient’s next steps. ‘It’s really irresponsible, I think, to forgo the recognition that this is a quantitative issue.’”

The problem is that current PCR tests are imprecisely calibrated. The PCR test, “amplifies genetic matter from the virus in cycles; the fewer cycles required, the greater the amount of virus, or viral load, in the sample. The greater the viral load, the more likely the patient is to be contagious.” The cycle threshold -- the “number of amplification cycles needed to find the virus… is never included in the results sent to doctors and Coronavirus patients [emphasis mine], although it could tell them how infectious the patients are.”

The Times story quotes Juliet Morrison, a virologist at the University of California, Riverside: “I’m shocked that people would think that 40 could represent a positive,” And Dr. Mina, who would set the cycle threshold limit at 30 or less, agrees. The change would mean, according to the Times story, “the amount of genetic material in a patient’s sample would have to be 100-fold to 1,000-fold that of the current standard for the test to return a positive result — at least, one worth acting on.”

Currently, the cycle threshold limit is set at 40, which means you are “positive for the Coronavirus if the test process required up to 40 cycles, or 37, to detect the virus.”

However, “’Tests with thresholds so high may detect not just live virus but also genetic fragments, leftovers from infection that pose no particular risk — akin to finding a hair in a room long after a person has left, Dr. Mina said.”

And the figures deployed by most politicians, in the absence of more useful and predictive figures, are designed to induce in ordinary citizens a posture of compliance to gubernatorial edicts that depend upon medically useless data.   

The Times, not a Trump apologist, quotes another virologist: “It’s just kind of mind-blowing to me that people are not recording the C.T. values from all these tests, that they’re just returning a positive or a negative.”

Not for nothing is Coronavirus called a “novel” virus. There can be no “science” associated with a novel virus. But there are scientists, continuing research, and necessary adjustments in perceptions and medical data. One wonders how many doctors and reporters in Connecticut would be thunderstruck, as were Mina and Morrison, that the “yes and no” figures dangled before them were, to put the best face on it, medically misleading but politically useful.


Comments

Popular posts from this blog

The Blumenthal Burisma Connection

Steve Hilton , a Fox News commentator who over the weekend had connected some Burisma corruption dots, had this to say about Connecticut U.S. Senator Dick Blumenthal’s association with the tangled knot of corruption in Ukraine: “We cross-referenced the Senate co-sponsors of Ed Markey's Ukraine gas bill with the list of Democrats whom Burisma lobbyist, David Leiter, routinely gave money to and found another one -- one of the most sanctimonious of them all, actually -- Sen. Richard Blumenthal."

Donna

I am writing this for members of my family, and for others who may be interested.   My twin sister Donna died a few hours ago of stage three lung cancer. The end came quickly and somewhat unexpectedly.   She was preceded in death by Lisa Pesci, my brother’s daughter, a woman of great courage who died still full of years, and my sister’s husband Craig Tobey Senior, who left her at a young age with a great gift: her accomplished son, Craig Tobey Jr.   My sister was a woman of great strength, persistence and humor. To the end, she loved life and those who loved her.   Her son Craig, a mere sapling when his father died, has grown up strong and straight. There is no crookedness in him. Thanks to Donna’s persistence and his own native talents, he graduated from Yale, taught school in Japan, there married Miyuki, a blessing from God. They moved to California – when that state, I may add, was yet full of opportunity – and both began to carve a living for them...

Lamont Surprised at Suit Brought Against PURA

Marissa P. Gillett, the state's chief utility regulator, watches Gov. Ned Lamont field questions about a new approach to regulation in April 2023. Credit: MARK PAZNIOKAS / CTMIRROR.ORG Concerning a suit brought by Eversource and Avangrid, Connecticut’s energy delivery agents, against Connecticut’s Public Utility Regulatory Agency (PURA), Governor Ned Lamont surprised most of the state’s political watchers by affecting surprise.   “Look,” Lamont told a Hartford Courant reporter shortly after the suit was filed, “I think it is incredibly unhelpful,” Lamont said. “Everyone is getting mad at the umpires.   Eversource is not getting everything they want and they are bringing suit. It was a surprise to me. Nobody notified me. I think we have to do a better job of working together.”   Lamont’s claim is far less plausible than the legal claim made by Eversource and Avangrid. The contretemps between Connecticut’s energy distributors and Marissa Gillett , Gov. Ned Lamont’s ...